Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/9841
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEkor, Martins-
dc.date.accessioned2023-10-23T11:34:52Z-
dc.date.available2023-10-23T11:34:52Z-
dc.date.issued2014-
dc.identifier.urihttp://hdl.handle.net/123456789/9841-
dc.description.abstractThe use of herbal medicinal products and supplements has increased tremendously over the past three decades with not less than 80% of people worldwide relying on them for some part of primary healthcare. Although therapies involving these agents have shown promising potential with the efficacy of a good number of herbal products clearly established, many of them remain untested and their use are either poorly monitored or not even monitored at all. The consequence of this is an inadequate knowledge of their mode of action, potential adverse reactions, contraindications, and interactions with existing orthodox pharmaceuticals and functional foods to promote both safe and rational use of these agents. Since safety continues to be a major issue with the use of herbal remedies, it becomes imperative, therefore, that relevant regulatory authorities put in place appropriate measures to protect public health by ensuring that all herbal medicines are safe and of suitable quality. This review discusses toxicity-related issues and major safety concerns arising from the use of herbal medicinal products and also highlights some important challenges associated with effective monitoring of their safety.en_US
dc.language.isoenen_US
dc.publisherFrontiers in Pharmacologyen_US
dc.subjectHerbal medicinesen_US
dc.subjectAdverse reactionsen_US
dc.subjectMonitoring safetyen_US
dc.subjectChallengesen_US
dc.subjectPublic healthen_US
dc.titleThe growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safetyen_US
dc.typeArticleen_US
Appears in Collections:School of Medical Sciences

Files in This Item:
File Description SizeFormat 
The growing use of herbal medicines issues relating to adverse reactions and challenges in monitoring safety.pdfMAIN ARTICLE408.52 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.